¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary carbon dioxide excess"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary culture
    ÀÏÂ÷¹è¾ç, óÀ½½É±â
  • primary degenerative dementia
    ¿ø¹ßÅðÇàÄ¡¸Å
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    ÀÏÂ÷Ä¡¾Æ
  • primary depression
    ¿ø¹ß¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary fissure
    ù°ƴ»õ, ¼Ò³úÁ¦ÀÏ¿­
  • primary focus
    ¿ø¹ßº´ÅÍ
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primary hair
    ÀÏÂ÷ÅÐ, ¹è³Á¼ØÅÐ
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary host
    Á¾¼÷ÁÖ
  • primary hypertension
    ¿ø¹ß¼º°íÇ÷¾Ð
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • primary impression
    ÀÏÂ÷Àλó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary depression
    ÀÏÂ÷¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • primary degenerative dementia
    ÀÏÂ÷ÅðÇàÄ¡¸Å
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • primary fissure
    ù°ƴ»õ
  • primary focus
    ¿øº´ÅÍ
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primary hair
    (¢¡lanugo) ¹è³Á¼ØÅÐ
  • primary host
    (¢¡definitive host) ÃÖÁ¾¼÷ÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
  • primary character
    ÀÏÂ÷¼º°Ý(¡­àõÌ«), ÀÏÂ÷¼º»ó(¡­àõßÒ).
  • primary circuit
    ÀÏÂ÷ȸ·Î(ÊÙÌ·ËÈ).
  • primary coil
    ÀÏÂ÷ÄÚÀÏ.
  • primary color =fundamental c.
    ¿ø»ö (ê«ßä).
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ).
  • primary complex
    Ãʱ⺯ȭ±º(ôøÑ¢Ü¨ûùÏØ)
  • primary constriction
    ÀÏÂ÷ÇùÂø(ìéó­úõó¸).
  • primary culture
    ÃÊ(´ë)¹è¾ç, ÀÏÂ÷¹è¾ç.
  • primary current
    ÀÏÂ÷Àü·ù(¡­ï³êü).
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • primary degenerative dementia
    ÀÏÂ÷¼º¡¡ÅðÇ༺ġ¸Å£¨ìéó­àõ¡¡÷Üú¼àõö¸ţ©£®
  • primary dentin
    ÀÏÂ÷<Á¦ÀÏ>»ó¾ÆÁú.
  • primary dentition
    ÀÏÂ÷<Á¦ÀÏ>»ýÄ¡(ìéó­<ð¯ìé>ßæöÍ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • excess sludge
    °úÀ×½½·¯Áö, °úÀ׿À´Ï.
  • excess zone, antibody
    Ç×ü°úÀ׿ª (Ç׿øÇ×ü¹ÝÀÀÀÇ)
  • excess zone, antigen
    Ç׿ø°úÀ׿ª
  • nutritional excess and imbalance
    ¿µ¾ç°ú´Ù(ç½å×ΦÒý) ¹× ºÒ±ÕÇü(ÝÕгû¬)
  • refractory anemia with excess blast =RAEB
    ¸ð¼¼Æ÷°ú´ÙºÒÀÀ¼ººóÇ÷
  • refractory anemia with excess blasts
    ¸ð¼¼Æ÷°ú´Ù¼º ºÒÀÀ¼ººóÇ÷
  • sludge excess
    °úÀ×(Ë´Ëö)½½·¯Áö.
  • type I << antibody excess >>
    IÇü << Ç×ü°úÀ× >>
  • vitamin a excess
    ºñŸ¹ÎA°úÀ×(Áõ)
  • vitamin d excess
    ºñŸ¹ÎD°úÀ×
  • active carbon
    Ȱ¼ºÅº(üÀàõ÷©).
  • asymmetric(al) carbon atom
    ºñ´ëĪź¼Ò¿øÀÚ.
  • carbon
    ź¼Ò(÷©áÈ).
  • carbon arc lamp
    ź¼Ò¾ÆÅ©µî
  • carbon clearance test
    ź¼ÒÁ¦°Å½ÃÇè.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • carbon radical
    ź¼Ò(÷©áÈ) ¶óµðÄ®
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • carbon skeleton
    ź¼Ò°ñ°Ý(÷©áÈÍéÌ«)
  • end carbon chain
    ³¡Åº¼Ò(÷©áÈ) »ç½½
  • epimeric carbon
    ¿¡ÇÇ¸Ó Åº¼Ò (÷©áÈ)
  • meso carbon
    ¸Þ¼Ò ź¼Ò(÷©áÈ)
  • one-carbon fragment
    ÀÏź¼Ò(ìé÷©áÈ) Á¶°¢
  • penultimate carbon
    ÀüÁ¾´Ü(îñðûÓ®) ź¼Ò(÷©áÈ)
  • single carbon unit
    ´Üź¼Ò´ÜÀ§(Ó¤÷©áÈÓ¤êÈ)
  • stereo carbon
    ÀÔü ź¼Ò(Ø¡ô÷÷©áÈ)
  • three-carbon plants
    »ïź¼Ò ½Ä¹° (ß²÷©áÈãÕÚª)
  • two-carbon fragment
    ÀÌź¼Ò(ì£÷©áÈ) Á¶°¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
QCO2 carbon dioxide evolution by a tissue
TCO2 total carbon dioxide
tcPCO2, tcPCO2 transcutaneous carbon dioxide pressure
VCO2, VCO2 carbon dioxide output
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
% e.e. enantiomeric excess
EPOC excess post-exercise O2 consumption
ERR excess relative risk
RAEB refractory anaemia with an excess of blasts
RAEB refractory anaemia with excess blasts
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary color
    ¿ø»ö, ±âº»»ö
    µ¿ÀǾî=fundamental color. È¥ÇÕ¿¡ ÀÇÇØ¼­ ´Ù¸¥ »ö±òÀ» ¸¸µå´Âµ¥ ÀÌ¿ëµÇ´Â 3°¡Áö ±âº»»öÀ¸·Î ºûÀÇ ºÎ°¡ÀûÀΠȥÇÕÀ̳ª Âø»öÁ¦¸¦ »« °ÍÀÌ´Ù.
  • primary colors subtractive
    °¨»ö
  • primary culture
    Ãʹè¾ç, ÃÊ´ë ¹è¾ç, ÀÏÂ÷ ¹è¾ç
  • primary degenerative dementia
    ¿ø¹ß¼º ÅðÇ༺ Ä¡¸Å
  • primary dentition
    À¯Ä¡¿­, ÀÏÂ÷ »ýÄ¡, Á¦ÀÏ»ýÄ¡
    óÀ½À¸·Î ¸ÍÃâµÇ´Â Ä¡¾Æ·Î º¸Åë ¿µ±¸Ä¡¿¡ ÀÇÇØ¼­ ±³È¯µÈ´Ù.
  • primary diagnosis
    ÀÏÂ÷ Áø´Ü
  • primary displacement
    ÀÏÂ÷¼º ÀüÀ§
  • primary emotional difficulty
    ¿ø¹ß¼º Á¤¼­ Àå¾Ö
  • primary epithelial band
    ÀÏÂ÷ »óÇÇ ¶ì
  • primary failure
    ÀÏÂ÷Àû ¹«È¿
  • primary foci
    ¿ø¹ß º´¼Ò
  • primary follicle
    ÀÏÂ÷ ³­Æ÷, ¿ø½Ã ³­Æ÷, ¿ø½Ã ¿©Æ÷
  • primary gain
    ÀÏÂ÷ À̵æ
  • primary headache
    ÀÏÂ÷ µÎÅë
  • primary hemorrhage
    ¿ø¹ß ÃâÇ÷, ¿ø¹ß¼º ÃâÇ÷, ÀÏÂ÷ ÃâÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
carbon-nitrogen ligases with glutamine as amide-n-donor <enzyme> Enzymes that catalyze the joining of glutamine-derived ammonia and another molecule. The linkage is in the form of a carbon-nitrogen bond.
Registry number: EC 6.3.5
(12 Dec 1998)
carbon-nitrogen lyases <enzyme> Enzymes that catalyze the cleavage of a carbon-nitrogen bond by means other than hydrolysis or oxidation. Subclasses are the ammonia-lyases, the amidine-lyases, the amine-lyases, and other carbon-nitrogen lyases.
Registry number: EC 4.3
(12 Dec 1998)
carbon-oxygen ligases <enzyme> Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond.
Registry number: EC 6.1
(12 Dec 1998)
carbon-oxygen lyases <enzyme> Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation.
Registry number: EC 4.2
(12 Dec 1998)
carbon-phosphorus lyase <enzyme> Found in bacteria which utilise alkyl and phenylphosphonic acids
Registry number: EC 4.99.-
Synonym: c-p lyase, carbon-phosphorus cleavage enzyme
(26 Jun 1999)
carbon radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.
(12 Dec 1998)
carbon source Any carbon-containing organic molecule (carbohydrate, aminoacid) that an organism can use to produce energy in the form of ATP.
(09 Oct 1997)
carbon-sulfur ligases <enzyme> Enzymes that catalyze the joining of two molecules by the formation of a carbon-sulfur bond.
Registry number: EC 6.2
(12 Dec 1998)
carbon-sulfur lyases <enzyme> Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation.
Registry number: EC 4.4
(12 Dec 1998)
carbon tetrachloride <chemical> Tetrachloromethane. A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal.
Chemical name: Methane, tetrachloro-
(12 Dec 1998)
quaternary carbon atom An atom of carbon to which four other carbon atom's are attached.
(05 Mar 2000)
one-carbon fragment The formyl group or the methyl group that takes part in transformylation or transmethylation reactions; by means of these reactions, a group containing a single carbon atom is added to a compound being biosynthesised, adding a methyl group (as in thymidine formation), adding a hydroxymethyl group (as in serine biosynthesis), or closing a ring (as in purine formation).
(05 Mar 2000)
one-carbon group transferases <enzyme> A subclass of transferases that transfer chemical groups containing a single carbon. These include the methyltransferases, the hydroxymethyl and formyl transferases, the carboxyl and carbamoyl transferases, and the amidinotransferases.
Registry number: EC 2.1
(12 Dec 1998)
two-carbon fragment The acetyl group (CH3CO-) that takes part in transacetylation reactions with coenzyme A as carrier; commonly referred to as acetate or acetic acid, from which it is derived.
(05 Mar 2000)
acute primary haemorrhagic meningoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • primary tenses
    (¶óƾ,±×¸®½º¾îÀÇ) Á¦ 1½ÃÁ¦(ÇöÀç,¹Ì·¡,°ú°Å ¶Ç´Â ¿Ï·áÀÇ ÃÑĪ)
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á